SELLAS Life Sciences Group Inc. (SLS) |
|
0.1526 -0.002 (-1.55%)
|
08-20 10:33 |
|
Open: |
0.1526 |
Pre. Close: |
0.155 |
|
High:
|
0.154 |
Low:
|
0.1509 |
|
Volume:
|
3,288,676 |
Market Cap:
|
34M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.16 - 0.161 |
0.161 - 0.162 |
|
Low:
|
0.148 - 0.149 |
0.149 - 0.15 |
|
Close:
|
0.159 - 0.16 |
0.16 - 0.161 |
|
Technical analysis |
as of: 2019-08-20 10:04:14 AM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 0.23 One year: 0.29 |
| Support: |
Support1: 0.12 Support2: 0.10 |
| Resistance: |
Resistance1: 0.20 Resistance2: 0.25 |
| Pivot: |
0.16 |
| Moving Average: |
MA(5): 0.16 MA(20): 0.16 
MA(100): 0.51 MA(250): 1.05 |
| MACD: |
MACD(12,26): -0.01 Signal(9): -0.01 |
| Stochastic oscillator: |
%K(14,3): 15.85 %D(3): 17.95 |
| RSI: |
RSI(14): 41.16 |
| 52-week: |
High: 2.46 Low: 0.10 Change(%): -82.5 |
| Average Vol(K): |
3-Month: 3039233 10-Days: 1766891 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.SLS has closed above bottom band by 13.6%. Bollinger Bands are 88.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to SLS's normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 05 Aug 2019 20:26:33 Z
Health Care Sector Update for 08/05/2019: SLS,ALLK,HSIC,HRTX
Wed, 31 Jul 2019 19:56:47 Z
Wednesday's ETF with Unusual Volume: VXF
Wed, 24 Jul 2019 10:06:47 Z
Validea Kenneth Fisher Strategy Daily Upgrade Report - 7/24/2019
Mon, 01 Jul 2019 14:35:48 Z
Validea's Top Five Technology Stocks Based On Peter Lynch - 7/1/2019
Sat, 22 Jun 2019 12:07:59 Z
NASA's Multibillion-Dollar Bet on the Moon: Good News for Space Companies, and for Taxpayers Too
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
25.18 |
| Shares Float (M) |
25.12 |
|
% Held by Insiders
|
2.04 |
|
% Held by Institutions
|
24.08 |
|
Shares Short (K)
|
2600 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.111 |
|
EPS Est. Current Year
|
|
|
EPS Est. Next Year
|
|
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
-2.839 |
|
Book Value (p.s.)
|
0.120 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-53.5 |
|
Return on Equity (ttm)
|
-2967.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-30.01 |
|
Levered Free Cash Flow (M)
|
-14.16 |
Stock Valuations |
|
P/E
|
-0.07 |
|
P/E Growth Ratio
|
-0.05 |
|
P/BV
|
1.27 |
|
P/S
|
|
|
P/CF
|
-0.13 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2018-01-02 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
